The Lyme Disease Tissue Collection Program is a collaborative initiative of the Lyme Disease Biobank (LDB), National Disease Research Interchange (NDRI), and MyLymeData Patient Registry. We are collecting surgical and post-mortem tissue samples and detailed information from people with Lyme disease and other tick-borne infections to aid in accelerating research efforts related to these diseases.
NDRI chats with Meghan Bradshaw, a Lyme Disease Patient Advocate discussing her commitment to being a living donor for the Lyme Disease Biobank
Founded in 1980, the National Disease Research Interchange (NDRI), is a non-profit 501(c)(3) that ships thousands of biospecimens annually from our nationwide procurement network to researchers worldwide. NDRI is the nation’s leading source of human tissues, cells, and organs for scientific research. The National Institutes of Health (NIH) has provided funding to NDRI since 1987.
NDRI is accredited by the College of American Pathologists (CAP) as a biorepository and a sponsor facility. This biorepository accreditation meets the standards for human biospecimen collection, storage, informatics, and distribution defined by the CAP Biorepository Accreditation Program.
Eligibility for the Lyme Disease Biobank Tissue Collection Program:
Thank you for completing the form and your interest in the Lyme Disease Biobank Tissue Program! NDRI's Private Donor team will be in touch with you soon!